enGene Therapeutics Inc. (ENGN)
NASDAQ: ENGN · Real-Time Price · USD
1.780
+0.010 (0.56%)
At close: Aug 21, 2026, 4:00 PM EDT
1.754
-0.026 (-1.46%)
After-hours: Aug 21, 2026, 7:30 PM EDT
enGene Therapeutics Market Cap
enGene Therapeutics has a market cap or net worth of $119.24 million as of August 21, 2026. Its market cap has decreased by -39.55% in one year.
Market Cap
119.24M
Enterprise Value
-105.87M
1-Year Change
-39.55%
Ranking
Category
Stock Price
$1.78
ChartMarket Cap Chart
Since February 1, 2022, enGene Therapeutics's market cap has decreased from $155.91M to $119.24M, a decrease of -23.52%. That is a compound annual growth rate of -5.72%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 21, 2026 | 119.24M | -80.29% |
| Dec 31, 2025 | 604.87M | 78.43% |
| Dec 31, 2024 | 338.99M | 58.32% |
| Dec 29, 2023 | 214.12M | 31.08% |
| Dec 30, 2022 | 163.34M | 4.77% |
| Feb 1, 2022 | 155.91M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Anixa Biosciences | 126.23M |
| Vivani Medical | 124.48M |
| Fractyl Health | 124.16M |
| Rani Therapeutics Holdings | 122.67M |
| Inovio Pharmaceuticals | 122.01M |
| Genelux | 121.89M |
| Nautilus Biotechnology | 121.47M |
| Outlook Therapeutics | 121.02M |